Skip to main content
Signal8
Anthony Todd M. profile photo

Todd M. Anthony

CIK: 0001969711

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CUMBERLAND PHARMACEUTICALS INC logo
CPIX

CUMBERLAND PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 18, 2026
    Award(A)

    Options (right to buy)

    Direct
    3K shares at avg. $2.80-
  • CUMBERLAND PHARMACEUTICALS INC logo
    CPIX

    CUMBERLAND PHARMACEUTICALS INC

    Mar 17, 2025
    Award(A)

    Options (right to buy)

    Direct
    3K shares at avg. $5.17-

1-2 of 2

About Anthony Todd M.

Anthony Todd M. (SEC CIK 0001969711) files insider reports with the SEC as Vice Pres Organizational Dev of CUMBERLAND PHARMACEUTICALS INC (CPIX).

Signal8 holds 2 ownership filings by Anthony Todd M., all Form 4s, filed between Mar 18, 2025 and Mar 20, 2026. Those filings report 2 transactions, from Mar 17, 2025 to Mar 18, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Anthony Todd M.'s filings is in NASHVILLE, TN.

Recent filings by Anthony Todd M.

  • Mar 18, 2026: Grant or award of CPIX derivative securities (Form 4, code A).
  • Mar 17, 2025: Grant or award of CPIX derivative securities (Form 4, code A).

Other insiders filing for CUMBERLAND PHARMACEUTICALS INC (CPIX)

How to read Form 4 transaction codes